Literature DB >> 19164297

Synthetic ciguatoxins selectively activate Nav1.8-derived chimeric sodium channels expressed in HEK293 cells.

Kaoru Yamaoka1, Masayuki Inoue, Keisuke Miyazaki, Masahiro Hirama, Chie Kondo, Eiji Kinoshita, Hiroshi Miyoshi, Issei Seyama.   

Abstract

The synthetic ciguatoxin CTX3C has been shown to activate tetrodotoxin (TTX)-sensitive sodium channels (Na(v)1.2, Na(v)1.4, and Na(v)1.5) by accelerating activation kinetics and shifting the activation curve toward hyperpolarization (Yamaoka, K., Inoue, M., Miyahara, H., Miyazaki, K., and Hirama, M. (2004) Br. J. Pharmacol. 142, 879-889). In this study, we further explored the effects of CTX3C on the TTX-resistant sodium channel Na(v)1.8. TTX-resistant channels have been shown to be involved in transducing pain and related sensations (Akopian, A. N., Sivilotti, L., and Wood, J. N. (1996) Nature 379, 257-262). Thus, we hypothesized that ciguatoxin-induced activation of the Na(v)1.8 current would account for the neurological symptoms of ciguatera poisoning. We found that 0.1 mum CTX3C preferentially affected the activation process of the Na(v)1.8 channel compared with those of the Na(v)1.2 and Na(v)1.4 channels. Importantly, without stimulation, 0.1 mum CTX3C induced a large leakage current (I (L)). The conductance of the I (L) calculated relative to the maximum conductance (G (max)) was 10 times larger than that of Na(v)1.2 or Na(v)1.4. To determine the molecular domain of Na(v)1.8 responsible for conferring higher sensitivity to CTX3C, we made two chimeric constructs from Na(v)1.4 and Na(v)1.8. Chimeras containing the N-terminal half of Na(v)1.8 exhibited a large response similar to wild-type Na(v)1.8, indicating that the region conferring high sensitivity to ciguatoxin action is located in the D1 or D2 domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164297      PMCID: PMC2658054          DOI: 10.1074/jbc.M806481200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain.

Authors:  N Yoshimura; S Seki; V Erickson; K Erickson; L Kassotakis; S Novakovic; M O Fraser; M B Chancellor; W C de Groat
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

2.  Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.

Authors:  Michael S Gold; Daniel Weinreich; Chang-Sook Kim; Ruizhong Wang; James Treanor; Frank Porreca; Josephine Lai
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

3.  5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels.

Authors:  L M Cardenas; C G Cardenas; R S Scroggs
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

4.  Total synthesis of ciguatoxin CTX3C.

Authors:  M Hirama; T Oishi; H Uehara; M Inoue; M Maruyama; H Oguri; M Satake
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

5.  Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8.

Authors:  Josephine Lai; Michael S Gold; Chang Sook Kim; Di Bian; Michael H Ossipov; John C Hunter; Frank Porreca
Journal:  Pain       Date:  2002-01       Impact factor: 6.961

6.  A role for the TTX-resistant sodium channel Nav 1.8 in NGF-induced hyperalgesia, but not neuropathic pain.

Authors:  B J Kerr; V Souslova; S B McMahon; J N Wood
Journal:  Neuroreport       Date:  2001-10-08       Impact factor: 1.837

Review 7.  The chemistry and biological function of natural marine toxins.

Authors:  T Yasumoto
Journal:  Chem Rec       Date:  2001       Impact factor: 6.771

8.  A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.

Authors:  Michael F Jarvis; Prisca Honore; Char-Chang Shieh; Mark Chapman; Shailen Joshi; Xu-Feng Zhang; Michael Kort; William Carroll; Brian Marron; Robert Atkinson; James Thomas; Dong Liu; Michael Krambis; Yi Liu; Steve McGaraughty; Katharine Chu; Rosemarie Roeloffs; Chengmin Zhong; Joseph P Mikusa; Gricelda Hernandez; Donna Gauvin; Carrie Wade; Chang Zhu; Madhavi Pai; Marc Scanio; Lei Shi; Irene Drizin; Robert Gregg; Mark Matulenko; Ahmed Hakeem; Michael Gross; Matthew Johnson; Kennan Marsh; P Kay Wagoner; James P Sullivan; Connie R Faltynek; Douglas S Krafte
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

9.  Annexin II light chain regulates sensory neuron-specific sodium channel expression.

Authors:  Kenji Okuse; Misbah Malik-Hall; Mark D Baker; W-Y Louisa Poon; Haeyoung Kong; Moses V Chao; John N Wood
Journal:  Nature       Date:  2002-06-06       Impact factor: 49.962

10.  Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice.

Authors:  Jennifer M A Laird; Veronika Souslova; John N Wood; Fernando Cervero
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

View more
  13 in total

Review 1.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

Review 2.  Animal toxins influence voltage-gated sodium channel function.

Authors:  John Gilchrist; Baldomero M Olivera; Frank Bosmans
Journal:  Handb Exp Pharmacol       Date:  2014

3.  Neurotoxins and their binding areas on voltage-gated sodium channels.

Authors:  Marijke Stevens; Steve Peigneur; Jan Tytgat
Journal:  Front Pharmacol       Date:  2011-11-09       Impact factor: 5.810

Review 4.  Total synthesis and related studies of large, strained, and bioactive natural products.

Authors:  Masahiro Hirama
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2016       Impact factor: 3.493

Review 5.  An Updated Review of Ciguatera Fish Poisoning: Clinical, Epidemiological, Environmental, and Public Health Management.

Authors:  Melissa A Friedman; Mercedes Fernandez; Lorraine C Backer; Robert W Dickey; Jeffrey Bernstein; Kathleen Schrank; Steven Kibler; Wendy Stephan; Matthew O Gribble; Paul Bienfang; Robert E Bowen; Stacey Degrasse; Harold A Flores Quintana; Christopher R Loeffler; Richard Weisman; Donna Blythe; Elisa Berdalet; Ram Ayyar; Danielle Clarkson-Townsend; Karen Swajian; Ronald Benner; Tom Brewer; Lora E Fleming
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

6.  Multiple sodium channel isoforms mediate the pathological effects of Pacific ciguatoxin-1.

Authors:  Marco C Inserra; Mathilde R Israel; Ashlee Caldwell; Joel Castro; Jennifer R Deuis; Andrea M Harrington; Angelo Keramidas; Sonia Garcia-Caraballo; Jessica Maddern; Andelain Erickson; Luke Grundy; Grigori Y Rychkov; Katharina Zimmermann; Richard J Lewis; Stuart M Brierley; Irina Vetter
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

7.  Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling.

Authors:  Irina Vetter; Filip Touska; Andreas Hess; Rachel Hinsbey; Simon Sattler; Angelika Lampert; Marina Sergejeva; Anastasia Sharov; Lindon S Collins; Mirjam Eberhardt; Matthias Engel; Peter J Cabot; John N Wood; Viktorie Vlachová; Peter W Reeh; Richard J Lewis; Katharina Zimmermann
Journal:  EMBO J       Date:  2012-07-31       Impact factor: 11.598

8.  Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening.

Authors:  Marc Rogers; Nace Zidar; Danijel Kikelj; Robert W Kirby
Journal:  Assay Drug Dev Technol       Date:  2016-03       Impact factor: 1.738

9.  Ionic mechanisms of spinal neuronal cold hypersensitivity in ciguatera.

Authors:  Ryan Patel; Nicola L Brice; Richard J Lewis; Anthony H Dickenson
Journal:  Eur J Neurosci       Date:  2015-11-13       Impact factor: 3.386

Review 10.  Ladder-Shaped Ion Channel Ligands: Current State of Knowledge.

Authors:  Yuri B Shmukler; Denis A Nikishin
Journal:  Mar Drugs       Date:  2017-07-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.